Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Medication, narcotics and behavior at the wheel]

C Mercier-Guyon1

  • 1CERMT, Centre d'Etudes et de Recherches en Médecine du Trafic, Annecy.

Bulletin De L'Academie Nationale De Medecine
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consumer perceptions of medication warnings about driving: a comparison of French and Australian labels.

Traffic injury prevention·2013
Same author

[Clinical and behavioral approach].

Annales pharmaceutiques francaises·2006
Same author

The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.

Current medical research and opinion·2004
Same author

Evaluation of alcohol consumption level in drivers when regranting licences after driving while intoxicated in France.

Alcohol and alcoholism (Oxford, Oxfordshire)·1996
Same journal

[Advances and perspectives in vascularized composite allotransplantation preservation].

Bulletin de l'Academie nationale de medecine·2025
Same journal

[COVID-19: Neurological manifestations and complications during the acute phase of the disease].

Bulletin de l'Academie nationale de medecine·2024
Same journal

[Role of psychological factors in post-COVID-19 condition].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[From the origin of Sars-CoV-2 to dangerous virology/biology].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[Neurological forms of long COVID in adults: Critical approach].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[Post-COVID-19 syndrome].

Bulletin de l'Academie nationale de medecine·2023
See all related articles

Illicit drug and medicine use significantly impacts road safety, yet current French law hinders immediate detection. A standardized testing methodology is crucial for assessing medication risks for drivers.

Area of Science:

  • Forensic Toxicology
  • Traffic Safety Research
  • Pharmacology

Context:

  • Illicit drug consumption is an underrecognized cause of road accidents.
  • French legislation lacks immediate drug detection capabilities for law enforcement.
  • Debate exists on decriminalizing certain drug use despite their role in road fatalities.

Purpose:

  • To highlight the underestimation of drug use in road accidents.
  • To address the limitations in current French legislation regarding drug detection.
  • To emphasize the need for a common methodology to assess medication risks for drivers.

Summary:

  • Current French law impedes immediate drug detection, contributing to underreported road accidents.
  • Medicinal drug influence on driver behavior is studied, but a lack of standardized testing prevents risk categorization.

Related Experiment Videos

  • A proposed methodology should evaluate risk-taking behavior, not just sedative effects, for accurate medication risk assessment.

    • Impact:

    • Informs legislative discussions on drug use and driving regulations.
    • Promotes the development of standardized testing for medication-related driving impairment.
    • Aims to improve road safety by addressing both illicit and medicinal drug risks.